IRUS Total

Implications of incidental findings from lung screening for primary care: data from a UK pilot

File Description SizeFormat 
s41533-021-00246-8.pdfPublished version434.83 kBAdobe PDFView/Open
Title: Implications of incidental findings from lung screening for primary care: data from a UK pilot
Authors: Bartlett, E
Belsey, J
Derbyshire, J
Morris, K
Chen, M
Addis, J
Martins, M
Ridge, CA
Desai, SR
Mirsadraee, S
Padley, S
Whiteside, S
Vaghani, P
Morjaria, JB
Kemp, SV
Devaraj, A
Item Type: Journal Article
Abstract: Regional lung cancer screening (LCS) is underway in England, involving a “lung health check” (LHC) and low-dose CT scan for those at high risk of cancer. Incidental findings from LHCs or CTs are usually referred to primary care. We describe the proportion of participants referred from the West London LCS pilot to primary care, the indications for referral, the number of general practitioner (GP) attendances and consequent changes to patient management, and provide an estimated cost-burden analysis for primary care. A small proportion (163/1542, 10.6%) of LHC attendees were referred to primary care, primarily for suspected undiagnosed chronic obstructive pulmonary disease (55/163, 33.7%) or for QRISK® (63/163, 38.7%) assessment. Ninety one of 159 (57.2%) participants consenting to follow-up attended GP appointments; costs incurred by primary care were estimated at £5.69/LHC participant. Patient management changes occurred in only 36/159 (22.6%) referred participants. LHCs result in a small increase to primary care workload provided a strict referral protocol is adhered to. Changes to patient management arising from incidental findings referrals are infrequent.
Issue Date: 7-Jun-2021
Date of Acceptance: 25-Apr-2021
URI: http://hdl.handle.net/10044/1/89577
DOI: 10.1038/s41533-021-00246-8
ISSN: 2055-1010
Publisher: Nature Research
Journal / Book Title: npj Primary Care Respiratory Medicine
Volume: 31
Copyright Statement: © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Publication Status: Published
Article Number: ARTN 36
Appears in Collections:National Heart and Lung Institute

This item is licensed under a Creative Commons License Creative Commons